E-DRUG: E-DRUG amoebic dysentry during pregnancy Response

["Pat McElhatton" <Patricia.McElhatton@newcastle.ac.uk>]

The choice of drugs for treatment of pregnant women, especially in 
the first trimester is always difficult.  However, there are 
instances where withholding treatment of the pregnant woman may have 
more serious deleterious effects on the fetus, than those allegedly 
associated with the treatment. 

In cases of amoebic dysentery it is important for the wellbeing of 
both the mother and the fetus to give appropriate treatment. In these 
circumstances the drug of choice is metronidazole. It has been used 
in pregnant women for a number of years and it has not been associated 
with an increased risk of spontaneous abortions or malformations. 
furthermore, there has been no significant increase in any particular 
types of malformations or syndromes.


Patricia.McElhatton@newcastle.ac.uk
--
Send mail for the `E-Drug' conference to `e-drug@usa.healthnet.org'.
Mail administrative requests to `majordomo@usa.healthnet.org'.
For additional assistance, send mail to:  `owner-e-drug@usa.healthnet.org'.